81
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren’s disease undergoing collagenase versus fasciectomy treatment

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 127-136 | Received 25 Mar 2020, Accepted 13 May 2020, Published online: 21 Jun 2020

References

  • Picardo NE, Khan WS. Advances in the understanding of the aetiology of Dupuytren’s disease. Surgeon. 2012 Jun;10(3):151–158. PubMed PMID: 22297148; eng.
  • Bayat A, Cunliffe EJ, McGrouther DA. Assessment of clinical severity in Dupuytren’s disease. Br J Hosp Med. 2007;68(11):604–609. PubMed PMID: 18087853; eng.
  • Anthony SG, Lozano-Calderon SA, Simmons BP, et al. Gender ratio of Dupuytren’s disease in the modern U.S. population. Hand (N Y). 2008 Jun;3(2):87–90. PubMed PMID: 18780082; PubMed Central PMCID: PMCPMC2529131. eng.
  • Dibenedetti DB, Nguyen D, Zografos L, et al. Prevalence, incidence, and treatments of Dupuytren’s disease in the United States: results from a population-based study. Hand (N Y). 2011;6(2):149–158. PubMed PMID: 21776198; eng.
  • NIH. Dupuytren contracture. 2020. Available from: https://ghr.nlm.nih.gov/condition/dupuytren-contracture#statistics
  • Mikkelsen OA. Dupuytren’s disease–initial symptoms, age of onset and spontaneous course. Hand. 1977 Feb;9(1):11–15. PubMed PMID: 892619; eng.
  • Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren’s contracture in men and women. J Hand Surg Br. 1999 Aug;24(4):456–459. PubMed PMID: 10473157; eng.
  • Bayat A, McGrouther DA. Management of Dupuytren’s disease–clear advice for an elusive condition. Ann R Coll Surg Engl. 2006;88(1):3–8. PubMed PMID: 16460628; eng.
  • Mitchell RJ, Bates P. Measuring health-related productivity loss. Popul Health Manag. 2011;14(2):93–98. PubMed PMID: 21091370; eng.
  • Macaulay D, Ivanova J, Birnbaum H, et al. Direct and indirect costs associated with Dupuytren’s contracture. J Med Econ. 2012;15(4):664–671. PubMed PMID: 22369346; eng.
  • Turesson C, Kvist J, Krevers B. Experiences of men living with Dupuytren’s disease-Consequences of the disease for hand function and daily activities. J Hand Ther. 2019:S0894-1130(18)30296–5. PubMed PMID: 31477329; eng. DOI:10.1016/j.jht.2019.04.004.
  • Soreide E, Murad MH, Denbeigh JM, et al. Treatment of Dupuytren’s contracture: a systematic review. Bone Joint J. 2018;100-B(9):1138–1145. PubMed PMID: 30168768; eng.
  • Eaton C. Evidence-based medicine: dupuytren contracture. Plast Reconstr Surg. 2014;133(5):1241–1251. PubMed PMID: 24776555; eng.
  • Bear BJ, Peimer CA, Kaplan FTD, et al. Treatment of recurrent Dupuytren contracture in joints previously effectively treated with collagenase clostridium histolyticum. J Hand Surg. 2017;42(5):391.e1–391.e8.
  • Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011;36(5):936–942.
  • Chen NC, Srinivasan RC, Shauver MJ, et al. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture. Hand. 6(3):250–255. 2011.
  • Peimer CA, Blazar P, Coleman S, et al. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data. J Hand Surg Am. 2015 Aug;40(8):1597–1605. PubMed PMID: 26096221; eng.
  • Dritsaki M, Rivero-Arias O, Gray A, et al. What do we know about managing Dupuytren’s disease cost-effectively? BMC Musculoskelet Disord. 2018;19(1):34. PubMed PMID: 29370792; eng.
  • Sanjuan Cervero R, Franco Ferrando N, Poquet Jornet J. Use of resources and costs associated with the treatment of Dupuytren’s contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy. BMC Musculoskelet Disord. 2013 Oct 14;14;14(1):293. PubMed PMID: 24125161; PubMed Central PMCID: PMCPMC3852948. eng.
  • Povlsen B, Shields AM, Bhabra GS. Resource utilisation associated with single digit Dupuytren’s contracture treated with either surgery or injection of collagenase Clostridium histolyticum. Hand Surg. 2014;19(2):205–209. PubMed PMID: 24875504; eng.
  • Naam NH. Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren’s contracture. Hand (N Y). 2013;8(4):410–416. PubMed PMID: 24426958; eng.
  • Atroshi I, Strandberg E, Lauritzson A, et al. Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren’s contracture: a retrospective cohort study. BMJ Open. 2014 Jan 15;4(1):e004166. PubMed PMID: 24435894; PubMed Central PMCID: PMCPMC3902506. eng.
  • IBM Watson Health. White paper. IBM MarketScan Research Databases for Health Services Researchers [Internet]. 2019 [cited 2020 Jan 29]. Available from: https://www.ibm.com/downloads/cas/6KNYVVQ2.
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005 Nov;43(11):1130–1139. PubMed PMID: 16224307; eng.
  • Charlson M, Wells MT, Ullman R, et al. The Charlson comorbidity index can be used prospectively to identify patients who will incur high future costs. PLoS One. 2014;9(12):e112479. PubMed PMID: 25469987; PubMed Central PMCID: PMCPMC4254512. eng.
  • Hindocha S. Risk factors, disease associations, and Dupuytren diathesis. Hand Clin. 2018 Aug;34(3):307–314. PubMed PMID: 30012291; eng.
  • Degreef I. Comorbidity in Dupuytren disease. Acta Orthop Belg. 2016 Sep;82(3):643–648. PubMed PMID: 29119908; eng.
  • Burge P, Hoy G, Regan P, et al. Smoking, alcohol and the risk of Dupuytren’s contracture. J Bone Joint Surg Br. 1997 Mar;79-B(2):206–210. PubMed PMID: 9119843; eng.
  • Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren’s disease. J Bone Joint Surg Br. 1984 May;66-B(3):322–325. PubMed PMID: 6725338; eng.
  • Morelli I, Fraschini G, Banfi AE. Dupuytren’s disease: predicting factors and associated conditions. A single center questionnaire-based case-control study. Arch Bone Jt Surg. 2017 Nov;5(6):384–393. PubMed PMID: 29299493; PubMed Central PMCID: PMCPMC5736887. eng.
  • United States Department of Labor. Economic news release: occupational employment and wages [Internet]. 2017 [cited 2020 Jan 14]. Available from: https://www.bls.gov/news.release/ocwage.htm.
  • Grant RL. Converting an odds ratio to a range of plausible relative risks for better communication of research findings. Bmj. 2014 Jan 24;348(jan24 1):f7450. PubMed PMID: 24464277; eng.
  • Bagalman E, Yu-Isenberg KS, Durden E, et al. Indirect costs associated with nonadherence to treatment for bipolar disorder. J Occup Environ Med. 2010 May;52(5):478–485. PubMed PMID: 20431414; eng.
  • Patriot Software. Short-term disability vs. long-term disability [Internet]. 2017 [cited 2020 Jan 29]. Available from: https://www.patriotsoftware.com/blog/payroll/difference-short-term-long-term-disability-insurance-coverage-qualify/.
  • Descatha A, Jauffret P, Chastang J-F, et al. Should we consider Dupuytren’s contracture as work-related? A review and meta-analysis of an old debate. BMC Musculoskelet Disord. 2011 May 16;12(1):96.
  • Leafblad ND, Wagner E, Wanderman NR, et al. Outcomes and direct costs of needle aponeurotomy, collagenase injection, and fasciectomy in the treatment of Dupuytren contracture. J Hand Surg Am. 2019 Nov;44(11):919–927. PubMed PMID: 31537401; eng.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.